Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE)

被引:195
作者
Hogg, RJ
Portman, RJ
Milliner, D
Lemley, KV
Eddy, A
Ingelfinger, J
机构
[1] N Texas Hosp Childrens Med City, Dallas, TX 75230 USA
[2] Univ Texas, Hlth Sci Ctr, Houston, TX USA
[3] Mayo Clin, Rochester, MN USA
[4] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[5] Childrens Hosp & Med Ctr, Seattle, WA 98105 USA
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
proteinuria; children; adolescents; nephrotic; nephrosis;
D O I
10.1542/peds.105.6.1242
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. The development of this review article evolved from a National Kidney Foundation consensus conference on recent advances in the importance of evaluating and treating proteinuria. From this conference, a series of recommendations for the evaluation of adults with proteinuria was published. Because specific pediatric aspects of the problem were outside the scope of the original National Kidney Foundation publication, an ad hoc committee of 6 pediatric nephrologists who were active participants in the National Kidney Foundation conference was established to provide primary care physicians with a concise, up-to-date reference on this subject. Methods. The recommendations that are given represent the consensus opinions of the authors. These are based on data from controlled studies in children when available, but many of the opinions are, by necessity, based on uncontrolled series in children or controlled trials performed in adults, because controlled trials in children have not been performed to evaluate many of the treatments described. Results and Conclusions. These recommendations are intended to provide primary care physicians with a useful reference when they are faced with a young child or teenager who presents with proteinuria, whether this is mild and asymptomatic or more severe, leading to nephrotic syndrome.
引用
收藏
页码:1242 / 1249
页数:8
相关论文
共 43 条
[1]  
[Anonymous], 1978, KIDNEY INT, V13, P159
[2]   Levamisole therapy in corticosteroid-dependent nephrotic syndrome [J].
Bagga, A ;
Sharma, A ;
Srivastava, RN .
PEDIATRIC NEPHROLOGY, 1997, 11 (04) :415-417
[3]  
BENNETT PH, 1995, AM J KIDNEY DIS, V25, P107
[4]   PROGRESSION OF ORTHOSTATIC PROTEINURIA TO FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS [J].
BERNS, JS ;
MCDONALD, B ;
GAUDIO, KM ;
SIEGEL, NJ .
CLINICAL PEDIATRICS, 1986, 25 (03) :165-166
[5]  
CAMERON JS, 1990, AM J NEPHROL, V10, P81
[6]  
Coleman JE, 1996, PEDIATR NEPHROL, V10, P171
[7]   ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR THERAPY TO DECREASE MICROALBUMINURIA IN NORMOTENSIVE CHILDREN WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
COOK, J ;
DANEMAN, D ;
SPINO, M ;
SOCHETT, E ;
PERLMAN, K ;
BALFE, JW .
JOURNAL OF PEDIATRICS, 1990, 117 (01) :39-45
[8]  
EDDY AA, 1991, AM J PATHOL, V138, P1111
[9]   PERITONITIS IN CHILDHOOD RENAL-DISEASE [J].
FEINSTEIN, EI ;
CHESNEY, RW ;
ZELIKOVIC, I .
AMERICAN JOURNAL OF NEPHROLOGY, 1988, 8 (02) :147-165
[10]  
Fivush B. A., 1999, Journal of the American Society of Nephrology, V10, p72A